Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on mRNA vaccine mediated in vivo dendritic cell reprogramming to elicit potent antitumor immune responses was published in ACS Nano
2025.10.28
Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on computer aided design of ionizable lipids to overcome liver accumulation of LNPs was published in Journal of the American Chemical Society
2025.10.13
Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on inhalable RNA therapeutics overcoming immunotherapy barriers in lung cancer was published in Nature Communications
2025.8.30
Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on steroid structured inhalable LNPs for co delivery of steroid drugs and anti TSLP mRNA for synergistic treatment of refractory asthma was published in Nature Communications 2025.7.1
Congratulations to MSc student Jia Huang (Class of 2022) on successful graduation June 25, 2025 2025.6.25
Congratulations to PhD student Chenshuang Zhang (Class of 2020) on successful graduation 2025.5.26
Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on inhalable lung targeted mRNA delivery was published in Nature Communications 2024.8.14
Collaborative research between Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University and Dr. Xiaoyang Xu’s group at New Jersey Institute of Technology on mRNA LNP mediated pyroptosis therapy to enhance cancer immunotherapy was published in Nature Communications
2023.7.15
Research from Dr. Xueqing Zhang’s group at Shanghai Jiao Tong University on a novel inhalable nucleic acid nanomedicine for the treatment of idiopathic pulmonary fibrosis was published in Science Advances 2022.6.22
